Duke-Robert J. Margolis, MD, Institute for Health Policy

Don't miss your chance to register! Our next event is coming up on Tuesday, June 23, where we will explore opportunities to modernize seasonal influenza vaccine development. The event will provide an overview of short- and long-term policy reform priorities from our forthcoming policy brief, followed by a panel discussion with stakeholders across the vaccine development landscape. Register today: https://duke.is/m/smgn

Join us for our annual State of Real-World Evidence Policy convening on July 27! This year, speakers will consider how real-world data and real-world evidence can routinely inform regulatory and coverage decisions, integrate research into patient care, and foster greater harmonization across the health policy ecosystem. Learn more and register here: https://duke.is/2/ynaf

Join us on July 15 for a hybrid workshop designed to inform a policy roadmap to improve the use of biomarkers and surrogate endpoints in regulatory decision-making for individual product submissions. Sessions will focus on biomarker-supported accelerated approvals and rare disease contexts, while considering lessons that may apply to broader therapeutic areas. Learn more and register here: https://duke.is/2/7sb2

Our next event is just a few weeks away! Join us on June 23 for a webinar where we will explore policy actions to enhance viral surveillance, data infrastructure, regulatory alignment and antigen selection to connect technical advancements towards strategies that facilitate a more efficient development of seasonal influenza vaccines. For more details on this discussion, check out the new draft agenda: https://duke.is/m/smgn

Missed out on the 2026 Health Policy Conference or want to review the discussion that took place? An event summary is now available to read and share! The summary provides quick highlights from each session and features some quotes from our speakers. Thank you again to everyone who made the conference possible, including sponsors, speakers, and staff—we are grateful to provide this space for important health policy conversations. Read the summary here: https://duke.is/HPC2026Summary

Influenza is a persistent public health challenge with significant morbidity, mortality, and economic costs. The seasonal influenza vaccination program is a time-sensitive, complex undertaking that remains one of the best interventions to mitigate disease burden. Next month, we are hosting a public webinar focused on prioritized policy actions to help realize innovative viral surveillance and development that leverage existing technical and manufacturing advancements. Learn more and register here: https://duke.is/m/smgn

We would like to extend our most sincere thanks to the Peterson Center on Healthcare for their support of our 2026 Health Policy Conference. The Center was established by the Peter G. Peterson Foundation to make higher-quality, more affordable health care a reality for all Americans. Its work strengthens America’s health data infrastructure, informs and improves health care purchasing, and fosters innovative solutions that reduce costs and make care more affordable, efficient, and effective. Learn more here: https://petersonhealthcare.org/

Our 2026 Health Policy Conference featured a group of wonderful speakers and timely health policy topics, but the conversation was only possible through the support of our sponsors. We offer our most sincere thanks to Johnson & Johnson for sponsoring this year’s conference. Johnson & Johnson has been tackling the world’s toughest health challenges for 140 years, aiming to keep people well at every age and every stage of life. They are working to build a world where complex diseases are prevented and cured, treatments are smarter and less invasive, and solutions are personal. Learn more here: https://www.jnj.com/

We extend our most sincere thanks to Alexandria Ventures for sponsoring our 2026 Health Policy Conference. Alexandria Ventures is the venture capital arm of Alexandria Real Estate Equities, Inc. Alexandria has been the pioneer of the life science real estate niche since their founding in 1994, as the preeminent and longest-tenured owner, operator, and developer of collaborative life science mega campuses in AAA innovation cluster locations. Their support will allow us to continue gathering annually and host these crucial health policy conversations. Learn more about Alexandria here: https://www.are.com/

Our annual conference is just a few days away! Join us this Wednesday, May 13, for an afternoon packed with timely health policy discussions as we celebrate 10 years of Duke-Margolis. Sessions will include:

- Next Generation Clinical Trials to Accelerate Cures
- By 2036: The Key Areas of Health Care Progress to Achieve in the Decade
- Incubator for Innovation: Mapping the Path Forward for State and Rural Health Transformation
- GLP-1 and Beyond: Securing the Promise of Transformative Therapies
- Employers as Engines of Health Care Transformation
- The Digital Health Imperative: Ignite Innovation that Empowers Patients, Improves Outcomes, and Lowers Costs

Register today: https://duke.is/HPC2026